Axitan Limited (10470976) is a private limited with share capital incorporated on 09/11/2016 (9 years old) and registered in london, EC3V3QQ. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Axitan is a uk biotech company focused on eliminating antibiotics from animal feed and improving productivity. it is developing a library of endolysins, and associated products, capable of targeting those pathogens that impact livestock farming historically managed through antibiotic supplements in ...
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:07-11-2023
Capital Allotment Shares
Category:Capital
Date:09-10-2023
Resolution
Category:Resolution
Date:27-04-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:11-04-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:06-04-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:11-04-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:01-04-2022
Change Person Director Company With Change Date
Category:Officers
Date:13-01-2022
Capital Allotment Shares
Category:Capital
Date:17-11-2021
Capital Allotment Shares
Category:Capital
Date:08-10-2021
Resolution
Category:Resolution
Date:20-09-2021
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:16-07-2021
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:12-07-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:12-04-2021
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-03-2021
Capital Allotment Shares
Category:Capital
Date:09-03-2021
Resolution
Category:Resolution
Date:01-03-2021
Resolution
Category:Resolution
Date:01-03-2021
Capital Allotment Shares
Category:Capital
Date:21-09-2020
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:11-09-2020
Mortgage Satisfy Charge Full
Category:Mortgage
Date:11-09-2020
Resolution
Category:Resolution
Date:08-09-2020
Second Filing Of Director Appointment With Name
Category:Officers
Date:25-08-2020
Confirmation Statement With Updates
Category:Confirmation Statement
Date:14-04-2020
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:01-04-2020
Change Person Director Company With Change Date
Category:Officers
Date:12-02-2020
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:12-02-2020
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:29-01-2020
Resolution
Category:Resolution
Date:02-12-2019
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-05-2019
Confirmation Statement With Updates
Category:Confirmation Statement
Date:10-04-2019
Legacy
Category:Capital
Date:26-02-2019
Capital Statement Capital Company With Date Currency Figure
Category:Capital
Date:26-02-2019
Capital Allotment Shares
Category:Capital
Date:18-02-2019
Capital Allotment Shares
Category:Capital
Date:18-02-2019
Legacy
Category:Insolvency
Date:18-02-2019
Resolution
Category:Resolution
Date:18-02-2019
Confirmation Statement With Updates
Category:Confirmation Statement
Date:08-11-2018
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:23-04-2018
Change Account Reference Date Company Previous Extended
Category:Accounts
Date:09-02-2018
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:10-01-2018
Mortgage Create With Deed With Charge Number Charge Creation Date
Category:Mortgage
Date:23-10-2017
Appoint Person Director Company With Name Date
Category:Officers
Date:25-08-2017
Appoint Person Director Company With Name Date
Category:Officers
Date:25-08-2017
Resolution
Category:Resolution
Date:16-12-2016
Incorporation Company
Category:Incorporation
Date:09-11-2016
Innovate Grants
2
This company received a grant of £69383.0 for Development Of A Novel Antimicrobial For The Treatment Of An Economically Important Disease In Chickens. The project started on 01/10/2017 and ended on 30/09/2018.
This company received a grant of £235862.9 for Antibiotic Replacement For Poultry. The project started on 01/10/2019 and ended on 31/03/2021.